BerandaAMRN • NASDAQ
add
Amarin Corporation PLC
$0,51
Setelah Jam Perdagangan Normal:(0,00%)0,00
$0,51
Tutup: 3 Mar, 16.00.13 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$0,54
Rentang hari
$0,51 - $0,55
Rentang tahun
$0,43 - $1,11
Kapitalisasi pasar
210,36Â jt USD
Volume Rata-Rata
983,04Â rb
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 42,30Â jt | -35,97% |
Biaya operasional | 41,44Â jt | -18,03% |
Laba bersih | -25,13Â jt | -30,15% |
Margin laba bersih | -59,42 | -103,28% |
Penghasilan per saham | -0,05 | — |
EBITDA | -24,42Â jt | -232,99% |
Tarif pajak efektif | -16,74% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 305,73Â jt | -4,66% |
Total aset | 750,62Â jt | -10,54% |
Total liabilitas | 219,24Â jt | -23,31% |
Total ekuitas | 531,38 jt | — |
Saham yang beredar | 411,34 jt | — |
Harga terhadap nilai buku | 0,42 | — |
Tingkat pengembalian aset | -8,12% | — |
Tingkat pengembalian modal | -11,43% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -25,13Â jt | -30,15% |
Kas dari operasi | -2,36Â jt | -132,20% |
Kas dari investasi | -56,55Â jt | -283,80% |
Kas dari pembiayaan | -68,00Â rb | 75,45% |
Perubahan kas bersih | -58,98Â jt | -255,95% |
Arus kas bebas | 13,04Â jt | 282,31% |
Tentang
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
Didirikan
1 Mar 1989
Kantor pusat
Situs
Karyawan
275
